194 related articles for article (PubMed ID: 1327800)
1. Limited involvement of interleukin-6 in the pathogenesis of lethal septic shock as revealed by the effect of monoclonal antibodies against interleukin-6 or its receptor in various murine models.
Libert C; Vink A; Coulie P; Brouckaert P; Everaerdt B; Van Snick J; Fiers W
Eur J Immunol; 1992 Oct; 22(10):2625-30. PubMed ID: 1327800
[TBL] [Abstract][Full Text] [Related]
2. The glucocorticoid antagonist RU38486 mimics interleukin-1 in its sensitization to the lethal and interleukin-6-inducing properties of tumor necrosis factor.
Brouckaert P; Everaerdt B; Fiers W
Eur J Immunol; 1992 Apr; 22(4):981-6. PubMed ID: 1532365
[TBL] [Abstract][Full Text] [Related]
3. Pathogenic role of interleukin-6 in the development of sepsis. Part II: Significance of anti-interleukin-6 and anti-soluble interleukin-6 receptor-alpha antibodies in a standardized murine contact burn model.
Pallua N; Low JF; von Heimburg D
Crit Care Med; 2003 May; 31(5):1495-501. PubMed ID: 12771624
[TBL] [Abstract][Full Text] [Related]
4. Anti-IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis factor-alpha challenge in mice.
Starnes HF; Pearce MK; Tewari A; Yim JH; Zou JC; Abrams JS
J Immunol; 1990 Dec; 145(12):4185-91. PubMed ID: 2124237
[TBL] [Abstract][Full Text] [Related]
5. Involvement of the liver, but not of IL-6, in IL-1-induced desensitization to the lethal effects of tumor necrosis factor.
Libert C; Van Bladel S; Brouckaert P; Shaw A; Fiers W
J Immunol; 1991 Apr; 146(8):2625-32. PubMed ID: 1849935
[TBL] [Abstract][Full Text] [Related]
6. Induction of interleukin 6 by human and murine recombinant interleukin 1 in mice.
Libert C; Brouckaert P; Shaw A; Fiers W
Eur J Immunol; 1990 Mar; 20(3):691-4. PubMed ID: 2318254
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-12 is required for interferon-gamma production and lethality in lipopolysaccharide-induced shock in mice.
Wysocka M; Kubin M; Vieira LQ; Ozmen L; Garotta G; Scott P; Trinchieri G
Eur J Immunol; 1995 Mar; 25(3):672-6. PubMed ID: 7705395
[TBL] [Abstract][Full Text] [Related]
8. Pathogenic role of interleukin-6 in the development of sepsis. Part I: Study in a standardized contact burn murine model.
Pallua N; von Heimburg D
Crit Care Med; 2003 May; 31(5):1490-4. PubMed ID: 12771623
[TBL] [Abstract][Full Text] [Related]
9. Comparative activity of Sant7 and anti-IL-6, IL-6R monoclonal antibodies in a murine model of B-cell lymphoma.
Campo S; Serlupi-Crescenzi O; Arseni B; Rossi S; Saggio I; Salone B; Cherubini G; Carminati P; De Santis R
Cytokine; 2005 Sep; 31(5):368-74. PubMed ID: 16061391
[TBL] [Abstract][Full Text] [Related]
10. Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia.
Eskandari MK; Bolgos G; Miller C; Nguyen DT; DeForge LE; Remick DG
J Immunol; 1992 May; 148(9):2724-30. PubMed ID: 1315357
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-1 receptor antibody (IL-1rab) protection and treatment against lethal endotoxemia in mice.
McNamara MJ; Norton JA; Nauta RJ; Alexander HR
J Surg Res; 1993 Apr; 54(4):316-21. PubMed ID: 8331925
[TBL] [Abstract][Full Text] [Related]
12. Administration of interleukin-10 at the time of priming protects Corynebacterium parvum-primed mice against LPS- and TNF-alpha-induced lethality.
Smith SR; Terminelli C; Denhardt G; Narula S; Thorbecke GJ
Cell Immunol; 1996 Nov; 173(2):207-14. PubMed ID: 8912878
[TBL] [Abstract][Full Text] [Related]
13. Control of endotoxin shock by the dried preparation of low virulent Streptococcus pyogenes OK-432.
Nose M; Uzawa A; Nomura M; Ikarashi Y; Nakata Y; Akashi M; Suzuki G
Cell Immunol; 1998 Sep; 188(2):97-104. PubMed ID: 9756639
[TBL] [Abstract][Full Text] [Related]
14. Cytokine production after intravenous or peritoneal gram-negative bacterial challenge in mice. Comparative protective efficacy of antibodies to tumor necrosis factor-alpha and to lipopolysaccharide.
Zanetti G; Heumann D; Gérain J; Kohler J; Abbet P; Barras C; Lucas R; Glauser MP; Baumgartner JD
J Immunol; 1992 Mar; 148(6):1890-7. PubMed ID: 1541827
[TBL] [Abstract][Full Text] [Related]
15. Urinary TNF-binding protein (TNF soluble receptor) protects mice against the lethal effect of TNF and endotoxic shock.
Bertini R; Delgado R; Faggioni R; Gascon MP; Ythier A; Ghezzi P
Eur Cytokine Netw; 1993; 4(1):39-42. PubMed ID: 8387827
[TBL] [Abstract][Full Text] [Related]
16. Bacterial lipoprotein and lipopolysaccharide act synergistically to induce lethal shock and proinflammatory cytokine production.
Zhang H; Peterson JW; Niesel DW; Klimpel GR
J Immunol; 1997 Nov; 159(10):4868-78. PubMed ID: 9366412
[TBL] [Abstract][Full Text] [Related]
17. Evidence for IFN-gamma as a mediator of the lethality of endotoxin and tumor necrosis factor-alpha.
Doherty GM; Lange JR; Langstein HN; Alexander HR; Buresh CM; Norton JA
J Immunol; 1992 Sep; 149(5):1666-70. PubMed ID: 1506688
[TBL] [Abstract][Full Text] [Related]
18. Enhanced release of interleukin-10 and soluble tumor necrosis factor receptors as novel principles of methylxanthine action in murine models of endotoxic shock.
Jilg S; Barsig J; Leist M; Küsters S; Volk HD; Wendel A
J Pharmacol Exp Ther; 1996 Jul; 278(1):421-31. PubMed ID: 8764378
[TBL] [Abstract][Full Text] [Related]
19. Recombinant IL-1 receptor antagonist protects against TNF-induced lethality in mice.
Everaerdt B; Brouckaert P; Fiers W
J Immunol; 1994 May; 152(10):5041-9. PubMed ID: 8176222
[TBL] [Abstract][Full Text] [Related]
20. High serum IL-6 level reflects susceptible status of the host to endotoxin and IL-1/tumor necrosis factor.
Yoshimoto T; Nakanishi K; Hirose S; Hiroishi K; Okamura H; Takemoto Y; Kanamaru A; Hada T; Tamura T; Kakishita E
J Immunol; 1992 Jun; 148(11):3596-603. PubMed ID: 1588048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
